Millennium Management’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.9K | Buy |
+10,582
| New | +$34.9K | ﹤0.01% | 3903 |
|
2025
Q1 | – | Sell |
-11,028
| Closed | -$25.6K | – | 3938 |
|
2024
Q4 | $25.6K | Buy |
+11,028
| New | +$25.6K | ﹤0.01% | 3956 |
|
2022
Q4 | – | Sell |
-36,249
| Closed | -$178K | – | 4751 |
|
2022
Q3 | $178K | Buy |
36,249
+17,051
| +89% | +$83.7K | ﹤0.01% | 4493 |
|
2022
Q2 | $59K | Sell |
19,198
-4,979
| -21% | -$15.3K | ﹤0.01% | 4804 |
|
2022
Q1 | $66K | Buy |
24,177
+8,465
| +54% | +$23.1K | ﹤0.01% | 4924 |
|
2021
Q4 | $47K | Buy |
+15,712
| New | +$47K | ﹤0.01% | 5000 |
|
2020
Q3 | – | Sell |
-39,304
| Closed | -$120K | – | 3574 |
|
2020
Q2 | $120K | Buy |
+39,304
| New | +$120K | ﹤0.01% | 3219 |
|
2016
Q2 | – | Sell |
-11,481
| Closed | -$35K | – | 2907 |
|
2016
Q1 | $35K | Sell |
11,481
-2,628
| -19% | -$8.01K | ﹤0.01% | 2928 |
|
2015
Q4 | $42K | Sell |
14,109
-21,892
| -61% | -$65.2K | ﹤0.01% | 3106 |
|
2015
Q3 | $171K | Buy |
+36,001
| New | +$171K | ﹤0.01% | 2954 |
|